Virus-neutralizing antibodies (Amgen/Adaptive Biotechnologies)

N/A

Report date: 2025/01/26 16:47:49

Base Information

Drug NameVirus-neutralizing antibodies (Amgen/Adaptive Biotechnologies)
Drug Alias Nameanti-SARS-CoV-2 antibodies (Amgen/Adaptive Biotechnologies)Fully human virus-neutralizing antibodies (Amgen/Adaptive Biotechnologies)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdaptive Biotechnologies CorpAmgen Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A